Author | Silva, Gilberto Marcelo Sperandio da | |
Author | Brasil, Pedro Emmanuel Alvarenga Americano do | |
Author | Mediano, Mauro Felippe Felix | |
Author | Hasslocher-Moreno, Alejandro Marcel | |
Author | Mejia, Roger Arteaga | |
Author | Fux, Carina Perotti | |
Author | Marchiol, Andrea | |
Author | Brum-Soares, Lucia Maria | |
Access date | 2023-04-15T01:23:47Z | |
Available date | 2023-04-15T01:23:47Z | |
Document date | 2015 | |
Identifier | https://f1000research.com/posters/1000027 | |
Citation | SILVA, Gilberto Marcelo Sperandio da et al. Adverse Drug Reactions after the use of Benznidazole in Bolivian Patients with Chagas Disease. In: MÉDECINS SANS FRONTIÈRES (MSF): SCIENTIFIC DAY, Londres, 7 a 8 de maio de 2015. 2 p. | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/57801 | |
Language | eng | en_US |
Rights | open access | en_US |
Subject in Portuguese | Doença de Chagas | en_US |
Subject in Portuguese | Benzonidazol | en_US |
Subject in Portuguese | Reação adversa a medicamentos | en_US |
Subject in Portuguese | Médicos sem Fronteiras | |
Title | Adverse Drug Reactions after the use of Benznidazole in Bolivian Patients with Chagas Disease | en_US |
Type | Papers presented at events | en_US |
DOI | 10.7490/f1000research.1000027.1 | |
Abstract | Chagas disease remains an important problem in the world and there is an estimate of more than 10 million infected people worldwide. Benznidazole (BZN) is the main drug used for etiologic treatment of this disease. However, about 17 to 31% of patients discontinued the BZN treatment. The aim of the present study was to understand the predictors of BZN treatment discontinuation over time.
Female sex, older patients, those who lived in urban areas, patients who had had moderate or severe ADRs and those who had had skin disorders had a higher risk for BZN treatment discontinuation. For these patients, a close follow-up should be carried out, at regular intervals of at least once a week to monitor BZN treatment. Impact of study: The results of this study may help to identify patients of high risk for BZN treatment discontinuation. Also, these results suggest that a close follow-up by health professionals could be necessary in order to improve adherence and early detection of adverse drug reactions. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | Médecins Sans Frontières. Operational Center. Barcelona (OCBA), Spain. | en_US |
Affilliation | Médecins Sans Frontières. Operational Center. Barcelona (OCBA), Spain. | en_US |
Affilliation | Médecins Sans Frontières. BRAMU (Brazilian Medical Unit). Médicos Sem Fronteiras. Rio de Janeiro, RJ, Brazil. | en_US |
Subject | Chagas disease | en_US |
Subject | Benznidazole | en_US |
Subject | Adverse drug reactions | en_US |
Event date | 2015 | |
Event Location | Londres | en_US |
Event title | Scientific Day, Medicins Sans Frontieres | en_US |
Event type | laboratory | en_US |